Gut response: Does benefit from immunotherapy depend on the bacteria in our intestines?
A spate of recent studies suggest that differences in population of bacteria and other micro-organisms that inhabit our intestines may be a key factor differentiating between people who respond to immune checkpoint inhibitors and those [more]